ICU Medical Schedules Important Q3 2024 Earnings Call Details
ICU Medical Announces Key Details for Third Quarter Earnings Call
ICU Medical, Inc. (Nasdaq: ICUI), known for its innovative medical products, has officially shared the schedule for its third quarter earnings call. Based in San Clemente, California, the company has established itself as a leader in the development and manufacturing of medical technologies designed for both hospital and home care settings.
Timing for Earnings Release and Conference Call
The firm's Q3 2024 results will be revealed on a Tuesday, with the expected release time set for approximately 4:00 p.m. ET (1:00 p.m. PT). Following this, an informative conference call is slated to begin at 4:30 p.m. ET (1:30 p.m. PT). All interested participants can join the discussion by dialing (800) 343-5172 and using the conference ID “ICUMED.”
Accessing the Live Webcast
For those who prefer a digital format, ICU Medical will also offer a live audio webcast of the conference call on their official website. By navigating to the Investor section of the site, listeners can easily access the webcast and follow the outlined instructions. This provides a convenient option for stakeholders and interested parties to engage with the company’s insights and performance metrics.
ICU Medical's Commitment to Quality and Innovation
About ICU Medical
As a global leader in infusion systems and critical care products, ICU Medical (Nasdaq: ICUI) is dedicated to making a meaningful impact in healthcare. The company's extensive portfolio is pivotal in hospital settings, alternate sites, and home care environments. With a steadfast focus on quality and innovation, ICU Medical strives to deliver superior value to healthcare professionals worldwide.
Contact Information
For any inquiries regarding the upcoming conference call or company operations, contact details for both ICU Medical and its associated firm are available. Brian Bonnell, Chief Financial Officer of ICU Medical, can be reached at (949) 366-2183. Additionally, John Mills, Managing Partner at ICR, Inc., is available at (646) 277-1254 for further assistance.
Frequently Asked Questions
What is the date of ICU Medical's Q3 2024 earnings release?
The earnings release is scheduled for a Tuesday in November, specific details will be provided during the call.
How can I join the conference call?
You can participate by calling (800) 343-5172 and entering the conference ID “ICUMED.”
Where can I access the webcast for the earnings call?
The webcast will be available on ICU Medical's official website under the Investors tab.
What is the main focus of ICU Medical?
The company specializes in infusion systems and high-value critical care products for various healthcare settings.
Who should I contact for more information?
You may reach out to Brian Bonnell, CFO at (949) 366-2183 or John Mills at (646) 277-1254 for inquiries.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.